« Legislators and Advocates Call For Passage of Bill to Protect People with Autism | Main | AofA Science Summary: Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism. »
Interagency Autism Coordinating Committee (IACC) Full Committee Meeting
Please join us for an IACC Full Committee meeting that will take place on Tuesday, July 10, 2012 from 9:00 a.m. to 5:00 p.m. ET at the L’Enfant Plaza Hotel in downtown Washington, DC. Onsite registration will begin at 8:00a.m.
Agenda: The Secretary of HHS will welcome new members of the committee and thank previous members for their service. The meeting will include presentations on autism research and policy issues, and the committee will discuss plans for future activities. Full agenda and available meeting materials will be posted on the IACC website prior to the meeting.
Meeting location:
L’Enfant Plaza Hotel - Map and Directions
408 L’Enfant Plaza
Washington, DC 20024
Nearest Metro stop:
L’Enfant Plaza – Orange, Blue, Yellow and Green Lines
The meeting will be open to the public and pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are pre-registered.
The meeting will be remotely accessible by videocast (http://videocast.nih.gov/) and conference call. Members of the public who participate using the conference call phone number will be able to listen to the meeting, but will not be heard.
Conference Call Access
USA/Canada Phone Number: 888-455-5419
Access code: 9404105
Individuals who participate using this service and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the contact person listed above at least seven days prior to the meeting. If you experience any technical problems with the webcast or conference call, please e-mail IACCTechSupport@acclaroresearch.com or call the IACC Technical Support Help Line at 443-680-0098.
Please visit the IACC Events page for the latest information about the meeting, including registration, remote access information, the agenda, materials, public comment and information about other upcoming IACC events.
Contact Person for this meeting is:
Ms. Lina Perez
Office of Autism Research Coordination
National Institute of Mental Health, NIH
6001 Executive Boulevard, NSC
Room 6182A
Rockville, MD 20852
Phone: 301-443-6040
E-mail: IACCpublicinquiries@mail.nih.gov
You can follow this conversation by subscribing to the comment feed for this post.
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
I agree Sarah - I think the upcoming election is the motivation.
Posted by: Shelly | June 21, 2012 at 05:46 PM
Because of the internet; I get to see this; and that is wonder of wonders.
I am looking forward to it.
It would be great if really something was going to take place, but I suppose even a dog and pony show is better than silence.
Posted by: Benedetta | June 21, 2012 at 05:30 PM
The cynical side of me thinks it's because the presidential election is coming up and Sebelius has to show she cares about autism since it effects so many American voters. I'd like to think she's sincere but it's too little to late on her part IMO.
Posted by: Sarah | June 21, 2012 at 01:32 PM
Thimerosal preserved flu vaccines contain 250 times more mercury than the minimum threshold level for D009 mercury hazardous waste. Mercury hazardous waste labels must be used for the disposal of these vaccines.
See:
http://www.ecy.wa.gov/programs/hwtr/hw_labels/hw.pdf
--and--
http://kimstagliano.blogspot.com/2008_03_01_archive.html
--and--
http://www.whale.to/a/wagnitz.html
So could someone please ask Secretary Sebelius why thimerosal preserved flu vaccines are recommended by the CDC and FDA as safe for children and pregnant women?
Also could someone please ask the Secretary that since the public was assured thirteen years ago that Thimerosal would be removed from vaccines “as soon as possible” then why hasn’t it been removed? Didn’t our mission to land on the moon take less time than that?
See
http://www.hhs.gov/asl/testify/t041005e.html
Posted by: Jim Thompson | June 21, 2012 at 03:24 AM
MS Sebelius at an IACC meeting? It's amazing that she's even interested. Sebelius has never been worried about autism so I wonder what her message will be.
IACC has called autism "a national health emergency." Does Sebelius agree? How much more money will be spent on genetic research in the face of an epidemic?
Will Sebelius be echoing Dr. Thomas Insel who said we need to prepare for a million people who'll be living off the taxpayers?
http://iacc.hhs.gov/strategic-plan/2011/introduction.shtml
IACC asks the question, "Why has there been such an increase in prevalence? What can be done to reverse this alarming trend? How can we improve the outcomes of people already affected, including youth and adults?"
It seems that "reversing this alarming trend" means changing the DSM regarding autism and POOF--autism is no problem.
Anne Dachel, Media
Posted by: Anne McElroy Dachel | June 20, 2012 at 09:55 AM